Persistent Symptoms After Lyme Disease: Clinical Characteristics, Predictors, and Classification

被引:0
|
作者
Baarsma, M. E. [1 ,2 ]
Hovius, Joppe W. [1 ,2 ]
机构
[1] Univ Amsterdam, Amsterdam Univ Med Ctr, Dept Internal Med, Div Infect Dis, Amsterdam, Netherlands
[2] Amsterdam Inst Immunol & Infect Dis, Amsterdam, Netherlands
来源
关键词
Lyme disease; posttreatment Lyme disease syndrome; PTLDS; persistent symptoms; inclusive classification; LONG-TERM ASSESSMENT; NEUROBORRELIOSIS; BORRELIOSIS; CULTURE; DEFINITION; PREVALENCE; SPECTRUM; FATIGUE;
D O I
10.1093/infdis/jiae203
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Persistent symptoms after an infection have been described for a number of infectious diseases, including Lyme disease. Studies have confirmed a moderate but consistent increase in the prevalence of such symptoms after Lyme disease, though the risk increase varies dependent on study design and the definition of persistent symptoms. Various possible predictors have been proposed, including a dysregulation of the immune system, metabolic changes, increased sensitization to pain signals, cognitive-behavioral factors, or-controversially-the persistence of the causative Borrelia bacteria or remnants thereof. Research on the precise roles of any of these factors is still ongoing. The lack of biological underpinning also makes it difficult to assess with certainty which patients' (generally nonspecific) persistent symptoms are etiologically related to the previous Lyme disease episode and which are not, particularly as these symptoms occur in the general population relatively frequently. The diagnostic criteria for posttreatment Lyme disease syndrome have shown their usefulness in both clinical and research settings but leave out a number of patients whose symptoms may fall just outside said criteria. Though the relationship between these symptoms and the previous Lyme disease episode may be very uncertain, we would argue that a uniform description and classification of these patients will aid in future research and patient management, regardless of the eventual underlying cause. Thus, we argue for an inclusive classification system for all persistent symptoms attributed to Lyme disease in order to promote validation of patient experiences and perspectives, while also maintaining scientific nuance regarding the very uncertain etiology of these patients' symptoms.
引用
收藏
页码:S62 / S69
页数:8
相关论文
共 50 条
  • [1] Persistent Symptoms After Treatment of Lyme Disease
    Marques, Adriana
    INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 2022, 36 (03) : 621 - 638
  • [2] Expectancies as predictors of symptom improvement after antimicrobial therapy for persistent symptoms attributed to Lyme disease
    Henriët van Middendorp
    Anneleen Berende
    Fidel J. Vos
    Hadewych H. M. ter Hofstede
    Bart Jan Kullberg
    Andrea W. M. Evers
    Clinical Rheumatology, 2021, 40 : 4295 - 4308
  • [3] Expectancies as predictors of symptom improvement after antimicrobial therapy for persistent symptoms attributed to Lyme disease
    van Middendorp, Henriet
    Berende, Anneleen
    Vos, Fidel J.
    ter Hofstede, Hadewych H. M.
    Kullberg, Bart Jan
    Evers, Andrea W. M.
    CLINICAL RHEUMATOLOGY, 2021, 40 (10) : 4295 - 4308
  • [4] Clinical trials validate the severity of persistent Lyme disease symptoms
    Cameron, Daniel J.
    MEDICAL HYPOTHESES, 2009, 72 (02) : 153 - 156
  • [5] Characteristics and predictors of persistent somatic symptoms in patients with cardiac disease
    Clifford, Caroline
    Loewe, Bernd
    Kohlmann, Sebastian
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [6] Persistent Symptoms, Lyme Disease, and Prior Trauma
    Mustafiz, Fayel
    Moeller, James
    Kuvaldina, Maria
    Bennett, Clair
    Fallon, Brian A.
    JOURNAL OF NERVOUS AND MENTAL DISEASE, 2022, 210 (05) : 359 - 364
  • [7] Update on persistent symptoms associated with Lyme disease
    Oliveira, Carlos R.
    Shapiro, Eugene D.
    CURRENT OPINION IN PEDIATRICS, 2015, 27 (01) : 100 - 104
  • [8] Post-treatment Lyme Disease as a Model for Persistent Symptoms in Lyme Disease
    Rebman, Alison W.
    Aucott, John N.
    FRONTIERS IN MEDICINE, 2020, 7
  • [9] Antiphospholipid antibodies in patients with persistent Lyme disease symptoms
    Stricker, R. B.
    Johnson, L.
    LUPUS, 2012, 21 (03) : 346 - 347
  • [10] Cognitive impairments in patients with persistent symptoms attributed to Lyme disease
    Berende, Anneleen
    van Rentergem, Joost Agelink
    Evers, Andrea W. M.
    ter Hofstede, Hadewych J. M.
    Vos, Fidel J.
    Kullberg, Bart Jan
    Kessels, Roy P. C.
    BMC INFECTIOUS DISEASES, 2019, 19 (01)